Glycyrrhetinic acid derivatives are mainly derived from glycyrrhetinic acid and glycyrrhizin, the main active components of licorice, and have glucocorticoid-like non-specific anti-inflammatory and hepatoprotective effects. Compound glycyrrhizin injection is mainly used for patients with viral hepatitis with abnormal liver function. It can also be used in combination with antiviral drugs for the recovery of chronic hepatitis C or chronic hepatitis B with abnormal liver function. Glycyrrhizin injection can also be used for patients with drug-related liver injury, and the drugs that cause liver damage need to be discontinued. For patients with alcoholic or non-alcoholic fatty liver disease with elevated transaminases, Compound Glycyrrhetinic Acid Injection can be used to lower transaminases.